Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA
journal contribution
posted on 2024-08-16, 04:27authored byVictor L Van de Wiele, Aaron S Kesselheim, Deborah GleesonDeborah Gleeson, Zhigang Lu, Sean S Tu, Benjamin N Rome
No description supplied
Funding
This project was funded by a grant from the Commonwealth Fund. Benjamin N. Rome, Sean S. Tu and Aaron S. Kesselheim also received support from Arnold Ventures. The funders had no role in the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication.
History
Publication Date
2024-07-14
Journal
Pharmaceutical Medicine
Volume
38
Pagination
8p. (p.303-310)
Publisher
Springer Science and Business Media LLC
ISSN
1178-2595
Rights Statement
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.